Abhishek Jain has a diverse work experience in the pharmaceutical industry. Abhishek is currently working as the F&D Team Manager at Harman Finochem Ltd since May 2022. Previously, they held the position of Senior Scientist at the same company from July 2020 to December 2022.
Prior to their current role, Abhishek worked at Zydus Pharmaceuticals Limited, starting as an Assistant Manager in April 2015 and later becoming a Deputy Manager in May 2017. Abhishek continued in this role until July 2020.
Abhishek also worked at Zydus Group as a Deputy Manager from April 2015 to July 2020.
Before joining Zydus, they were employed at Torrent Pharmaceuticals Ltd as a Formulation Scientist from February 2014 to April 2015. Their responsibilities included formulation and development of various solid oral, semi-solid, and liquid dosage forms, as well as product development and technology transfer.
Abhishek gained experience in formulation and development during their time at Cadila Pharmaceuticals. Abhishek worked as a Formulation and Development professional from February 2011 to January 2014. Abhishek also served as a Project Trainee from August 2010 to February 2011, where they completed their M. Pharm project and assisted the Technology Transfer Group.
In addition, Abhishek worked at West Coast Pharmaceuticalworks Ltd as a Formulation and Development professional from April 2010 to November 2010.
Throughout their career, Abhishek has gained expertise in various aspects of pharmaceutical formulation and development, including QbD implementation, reverse engineering, IVIVC, DoE, and PAT. Abhishek has also been involved in technology transfer, scale-up batches, and troubleshooting of pharmaceutical dosage forms.
Abhishek Jain completed their Bachelor of Pharmacy (B.Pharm.) degree in Pharmacology, Pharmaceutics, and Drug Design from Arihant School of Pharmacy and B.R.I. from 2005 to 2009. Abhishek then pursued a Master's degree in Pharmaceutics and Drug Design from Shree Swaminarayan Sanskar Pharmacy College from 2009 to 2011.
April 1, 2024 - present
May, 2022
July, 2020